NASH frontrunner Intercept Pharma is well on its way to market—it’s already filed Ocaliva for FDA review and will soon follow up with a filing in Europe. But in the ...

Finding the perfect name is no easy task for a new company, particularly in the exotic world of biopharma monikers. Mylan and Pfizer's Upjohn, working to close ...

Ubiquigent Limited (Ubiquigent) and LEO Pharma A/S announced today that they have entered into an option agreement granting LEO Pharma access to two novel compounds....

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosi...

Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (sBLA) for Nplate® (romip...

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a...

5 - 7 November 2019, Frankfurt, Germany.CPhI Worldwide - the world's largest pharma event taking place in Frankfurt - has released the first part of its eponymous 20...

Northwestern Medicine scientists have used patient-derived neurons to develop and test a new strategy to treat Parkinson's disease by mitigating the effects of harmf...

Germany consolidates itself as world leader in pharma according to the CPhI Pharma Index Frankfurt, 24th October 2019: Research conducted by CPhI Worldwi...

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solution...